Instructions for Sinupret film-coated tablets No. 50
Composition
active ingredients: 1 tablet contains dried medicinal plants in powder form:
Gentian root (Radix Gentianae) 6 mg,
primrose flowers with a calyx (Flores Primulae cum Calybus) 18 mg,
sorrel herb (Herba Rumіs) 18 mg,
elderflower (Flores Sambuci) 18 mg,
verbena herb (Nerba Verbenae) 18 mg;
excipients: calcium carbonate (E 170), castor oil, colloidal anhydrous silica, acrylate copolymer, gelatin, glucose, lactose monohydrate, light magnesium oxide, aluminum hydroxide, copper chlorophyllin (E 141), riboflavin (E 101), corn starch, dextrin, glycolic montan wax, potato starch, purified water, shellac, sorbitol (E 420), stearic acid, sucrose, talc, titanium dioxide (E 171), indigo carmine (E 132).
Dosage form
Film-coated tablets.
Main physicochemical properties: round biconvex tablets, coated with a green shell with a smooth surface.
Pharmacotherapeutic group
Drugs used for coughs and colds. ATX code R05X.
Pharmacological properties
The components that make up the herbal medicine have complex activity, which is manifested in secretolytic action, anti-edematous, anti-inflammatory, immunostimulating and antiviral effects.
The active ingredients of the drug Sinupret inhibit the reproduction of various respiratory viruses, such as influenza A virus, parainfluenza, and RSV (respiratory syncytial virus).
Under the influence of the drug, secretion is regulated and tissue edema is reduced. Drainage and ventilation of the paranasal sinuses are restored, nasal congestion is eliminated, the protective function of the respiratory tract epithelium is normalized. The effectiveness of antibiotic therapy is increased.
Indication
Acute and chronic inflammation of the paranasal sinuses.
Contraindication
Hypersensitivity to any of the active or auxiliary components of the drug, to other types of primrose, as well as peptic ulcer.
Interaction with other medicinal products and other types of interactions
No interactions with other drugs have been observed. Combination with antibiotics is possible and advisable.
Application features
It is recommended to consult a doctor if the patient experiences severe symptoms of rhinosinusitis, such as nosebleeds, fever, severe pain, purulent nasal discharge, visual impairment, asymmetry of the midface or eyes, and facial numbness, as urgent medical treatment may be required.
If symptoms persist for more than 7–14 days, worsen, or recur periodically, you should consult a doctor.
Special care should be taken when using the drug in patients with gastritis or functional dyspepsia (the so-called "sensitive stomach"). The drug should be taken after a meal with a sufficient amount of liquid (for example, a glass of water).
The drug contains glucose, lactose, sucrose and sorbitol. Therefore, patients with hereditary fructose intolerance, galactose intolerance, lactase deficiency, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take the drug.
Note for diabetics: 1 film-coated tablet contains an average of 0.01 bread units.
Use during pregnancy or breastfeeding
During pregnancy or breastfeeding, the drug should be used with caution and only after a doctor has clearly established the diagnosis and assessed the benefit-risk ratio for the mother and the fetus (child).
Ability to influence reaction speed when driving vehicles or other mechanisms
There are no special precautions.
Method of administration and doses
Unless otherwise prescribed by a doctor, adults and children over 12 years of age should take 2 tablets 3 times a day, children aged 6 to 11 years - 1 tablet 3 times a day.
The tablets should be swallowed without chewing, with sufficient liquid.
Typically, the recommended course of treatment is 7–14 days.
You should follow the recommendations set out in the “Special Instructions for Use” section of the instructions.
Children. Due to lack of experience, it is not recommended to use in children under 6 years of age. For the treatment of preschool children (under 6 years of age), who are prescribed lower doses, Sinupret should be used in the form of drops or syrup.
Overdose
Cases of overdose are currently unknown. If the dose is exceeded, the listed side effects may be aggravated - in this case, you should consult a doctor.
If you take doses that exceed the recommended ones, you should inform your doctor so that he or she can decide on the necessary measures.
Adverse reactions
Gastrointestinal disorders, including stomach pain, nausea, diarrhea, vomiting, abdominal discomfort, are uncommon. Hypersensitivity reactions, including rash, skin redness, itching, urticaria, angioedema, shortness of breath, facial swelling, are possible.
If any adverse reactions occur, you should stop using the drug and consult a doctor.
Expiration date
3 years.
Do not use after the expiry date stated on the packaging.
The expiration date determines the use of the drug until the last day of the specified month.
Storage conditions
Store in the original packaging at a temperature not exceeding 30 °C, out of the reach of children.
Packaging
50 tablets in blisters placed in a cardboard box.
Vacation category
Without a prescription.
Manufacturer/Applicant
Bionorica SE.
Location of the manufacturer and its business address/location of the applicant and/or the applicant's representative.
Kerchensteinerstrasse, 11-15, 92318, Neumarkt, Germany/
Kerschensteinerstrasse, 11-15, 92318 Neumarkt, Germany.
Contact details of the manufacturer's representative in Ukraine, LLC "Bionorika":
phone: 044 521 86 00; fax: 044 521 86 01, info@bionorica.ua
